Ryan Zurakowski

1.8k total citations
56 papers, 1.3k citations indexed

About

Ryan Zurakowski is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Ryan Zurakowski has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Virology, 26 papers in Infectious Diseases and 13 papers in Immunology. Recurrent topics in Ryan Zurakowski's work include HIV Research and Treatment (41 papers), HIV/AIDS drug development and treatment (19 papers) and HIV/AIDS Research and Interventions (17 papers). Ryan Zurakowski is often cited by papers focused on HIV Research and Treatment (41 papers), HIV/AIDS drug development and treatment (19 papers) and HIV/AIDS Research and Interventions (17 papers). Ryan Zurakowski collaborates with scholars based in United States, Spain and Colombia. Ryan Zurakowski's co-authors include Michael J. Piovoso, Andrew R. Teel, Javier Martínez‐Picado, María J. Buzón, Eric Rosenberg, Florencia Pereyra, Zhengyu Ouyang, Mathias Lichterfeld, Enrique Martín‐Gayo and Bruce D. Walker and has published in prestigious journals such as Nature Medicine, PLoS ONE and Journal of Virology.

In The Last Decade

Ryan Zurakowski

55 papers receiving 1.3k citations

Peers

Ryan Zurakowski

VIROL

IMMUN

PHEOH

Esteban A. Hernandez‐Vargas Germany

D L Birx United States

Hee‐Dae Kwon South Korea

Marc De Bruyère Belgium

Brian M. Adams United States

Daniel B. Sheffer United States

Senthil Kannan United States

Jacob Hurst United Kingdom

Noura Yousfi Morocco

Xiangyun Liao China

Esteban A. Hernandez‐Vargas Germany

Ryan Zurakowski

186 ×0.2

VIROL

467 ×0.9

297 ×0.7

IMMUN

445 ×2.4

PHEOH

93 ×0.6

Citations per year, relative to Ryan Zurakowski Ryan Zurakowski (= 1×) peers Esteban A. Hernandez‐Vargas

Countries citing papers authored by Ryan Zurakowski

Since Specialization

Citations

This map shows the geographic impact of Ryan Zurakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Zurakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Zurakowski more than expected).

Fields of papers citing papers by Ryan Zurakowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Zurakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Zurakowski. The network helps show where Ryan Zurakowski may publish in the future.

Co-authorship network of co-authors of Ryan Zurakowski

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Zurakowski. A scholar is included among the top collaborators of Ryan Zurakowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Zurakowski. Ryan Zurakowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piovoso, Michael J., et al.. (2023). Ongoing HIV replication in lymph node sanctuary sites in treated individuals contributes to the total latent HIV at a very slow rate. Journal of Theoretical Biology. 575. 111651–111651. 1 indexed citations

Nelson, Katherine M., et al.. (2020). Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression. Cellular and Molecular Bioengineering. 13(4). 259–284. 7 indexed citations

Rullo, Emmanuele Venanzi, Marilia Rita Pinzone, Manuela Ceccarelli, et al.. (2020). Persistence of an intact HIV reservoir in phenotypically naive T cells. JCI Insight. 5(20). 39 indexed citations

Piovoso, Michael J., et al.. (2020). An Integrated Spatial Dynamics—Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes. Frontiers in Bioengineering and Biotechnology. 8. 667–667. 8 indexed citations

Piovoso, Michael J., et al.. (2019). Positive Feedback Through Inflammation Creates Bistable Behavior in HIV Tissue Sanctuaries. PubMed. 2019. 3456–3461. 1 indexed citations

Vargas-García, Cesar A., et al.. (2018). HIV 2-LTR experiment design optimization. PLoS ONE. 13(11). e0206700–e0206700. 2 indexed citations

Abraham, George, et al.. (2016). Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design. PubMed. 2016. 5597–5602. 2 indexed citations

Vargas-García, Cesar A., et al.. (2016). Prospective HIV clinical trial comparison by expected Kullback-Leibler Divergence. PubMed. 4. 1295–1300. 6 indexed citations

Buzón, María J., Hong Sun, Chun Li, et al.. (2014). HIV-1 persistence in CD4+ T cells with stem cell–like properties. Nature Medicine. 20(2). 139–142. 313 indexed citations

10.

Cardozo-Ojeda, E. Fabián, et al.. (2014). Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification. Journal of Theoretical Biology. 345. 61–69. 18 indexed citations

11.

Piovoso, Michael J., et al.. (2014). Estimation of saturated data using the Tobit Kalman filter. 4151–4156. 28 indexed citations

12.

Piovoso, Michael J., et al.. (2012). HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics. PLoS ONE. 7(7). e40198–e40198. 55 indexed citations

13.

Zurakowski, Ryan, et al.. (2012). Resistance evolution in HIV — Modeling when to intervene. PubMed. 170. 4053–4058. 1 indexed citations

14.

Cardozo-Ojeda, E. Fabián & Ryan Zurakowski. (2012). Robust Closed-Loop Minimal Sampling Method for HIV Therapy Switching Strategies. IEEE Transactions on Biomedical Engineering. 59(8). 2227–2234. 7 indexed citations

15.

Cardozo-Ojeda, E. Fabián & Ryan Zurakowski. (2011). Measurement error robustness of a closed-loop minimal sampling method for HIV therapy switching. PubMed. 2011. 116–119. 3 indexed citations

16.

Zurakowski, Ryan. (2011). Nonlinear observer output-feedback MPC treatment scheduling for HIV. BioMedical Engineering OnLine. 10(1). 40–40. 19 indexed citations

17.

Rosero, Esteban & Ryan Zurakowski. (2010). Closed-loop minimal sampling method for determining viral-load minima during switching. PubMed. 2010. 460–461. 5 indexed citations

18.

Piovoso, Michael J., et al.. (2010). Modeling-error robustness of a viral-load preconditioning strategy for HIV treatment switching. PubMed. 2010. 5155–5160. 5 indexed citations

19.

Zurakowski, Ryan & Andrew R. Teel. (2005). A model predictive control based scheduling method for HIV therapy. Journal of Theoretical Biology. 238(2). 368–382. 129 indexed citations

20.

Zurakowski, Ryan, Michael J. Messina, S. Emre Tuna, & Andrew R. Teel. (2004). HIV treatment scheduling via robust nonlinear model predictive control. Asian Control Conference. 1. 25–32. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact